Tag: Dexpramipexole
-
Health
Slowing ALS symptom progression
Harvard researchers find that treatment with dexpramipexole — a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell’s energy — appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS).